Sandy Cobden - Pactiv Evergreen Chief Compliance
| PTVE Stock | USD 13.50 0.14 1.03% |
Executive
Sandy Cobden is Chief Compliance of Pactiv Evergreen
| Address | 1900 West Field Court, Lake Forest, IL, United States, 60045 |
| Phone | 847 482 2000 |
| Web | https://pactivevergreen.com |
Pactiv Evergreen Management Efficiency
The company has return on total asset (ROA) of 0.0208 % which means that it generated a profit of $0.0208 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1346) %, meaning that it created substantial loss on money invested by shareholders. Pactiv Evergreen's management efficiency ratios could be used to measure how well Pactiv Evergreen manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.06. In addition to that, Return On Capital Employed is expected to decline to 0. At present, Pactiv Evergreen's Non Current Assets Total are projected to decrease significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 217.3 M, whereas Intangible Assets are forecasted to decline to about 953.8 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Bendukai JD | Stepstone Group | N/A | |
| Robert JD | Pmv Pharmaceuticals | 62 | |
| Marc MD | Pmv Pharmaceuticals | N/A | |
| Anthony Keathley | Stepstone Group | 42 | |
| Robert Ticktin | Pmv Pharmaceuticals | 62 | |
| Seth Weiss | Stepstone Group | N/A | |
| Jennie OBrien | Broadstone Net Lease | 41 | |
| Rich Kasnia | Stepstone Group | N/A | |
| Will Garner | Broadstone Net Lease | N/A | |
| David Watson | Reynolds Consumer Products | 65 | |
| Thomas Keck | Stepstone Group | 58 | |
| Crystal Zuckerman | Pmv Pharmaceuticals | N/A | |
| John Coelho | Stepstone Group | 49 | |
| Jennifer Ishiguro | Stepstone Group | N/A | |
| Valerie Richards | Reynolds Consumer Products | 51 | |
| Michael Carulli | Pmv Pharmaceuticals | 50 | |
| Mark Swartzberg | Reynolds Consumer Products | 57 | |
| Maribel Yoo | Stepstone Group | N/A | |
| Binh Vu | Pmv Pharmaceuticals | N/A | |
| Scott Huckins | Reynolds Consumer Products | 57 | |
| Tim Smith | Pmv Pharmaceuticals | N/A | |
Management Performance
| Return On Equity | -0.13 | ||||
| Return On Asset | 0.0208 |
Pactiv Evergreen Leadership Team
Elected by the shareholders, the Pactiv Evergreen's board of directors comprises two types of representatives: Pactiv Evergreen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pactiv. The board's role is to monitor Pactiv Evergreen's management team and ensure that shareholders' interests are well served. Pactiv Evergreen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pactiv Evergreen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Curt Worthington, Vice Relations | ||
| Mark Dutt, VP Technology | ||
| Chandra Mitchell, Chief Secretary | ||
| Chandra JD, Chief Secretary | ||
| Timothy Levenda, President Foodservice | ||
| Jonathan Baksht, Chief officer | ||
| Eric Wulf, President Merchandising | ||
| Mike Betz, Chief Officer | ||
| Dhaval Patel, VP Strategy | ||
| Tommy Darby, Chief Officer | ||
| Douglas Owenby, Chief Officer | ||
| Michael King, CEO President | ||
| Danny Phillips, Vice Merchandising | ||
| Beth Kelly, Senior Communications | ||
| Sandy Cobden, Chief Compliance | ||
| JD Bowlin, Chief Officer |
Pactiv Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Pactiv Evergreen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.13 | ||||
| Return On Asset | 0.0208 | ||||
| Profit Margin | (0.03) % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 6.06 B | ||||
| Shares Outstanding | 179.29 M | ||||
| Shares Owned By Insiders | 77.71 % | ||||
| Shares Owned By Institutions | 24.31 % | ||||
| Number Of Shares Shorted | 1.21 M | ||||
| Price To Earning | 9.06 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Pactiv Evergreen is a strong investment it is important to analyze Pactiv Evergreen's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pactiv Evergreen's future performance. For an informed investment choice regarding Pactiv Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pactiv Evergreen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For information on how to trade Pactiv Stock refer to our How to Trade Pactiv Stock guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Paper & Plastic Packaging Products & Materials space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pactiv Evergreen. If investors know Pactiv will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pactiv Evergreen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.23) | Dividend Share 0.4 | Earnings Share (0.93) | Revenue Per Share 28.949 | Quarterly Revenue Growth (0.03) |
The market value of Pactiv Evergreen is measured differently than its book value, which is the value of Pactiv that is recorded on the company's balance sheet. Investors also form their own opinion of Pactiv Evergreen's value that differs from its market value or its book value, called intrinsic value, which is Pactiv Evergreen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pactiv Evergreen's market value can be influenced by many factors that don't directly affect Pactiv Evergreen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pactiv Evergreen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pactiv Evergreen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pactiv Evergreen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.